ABclonal is a company founded in 2016 and based in Woburn, Massachusetts, United States. It specialises in providing high quality reagents and services for biological research.
The company Focuses on providing custom antibody services. Its main goal at the initial stage was to improve the quality of scientific research by providing better antibodies. However, it has not stopped there, but has started the Human Genome Antibody Project, which aims to document and produce an antibody for every protein encoded in the human genome.
ABclonal is also developing its own next-generation sequencing technology with the help of its experienced molecular biologists and geneticists. Its goal is to create the most innovative next-generation library sequencing kits, while integrating bioinformatics platforms.
ABclonal’s products include next-generation sequencing kits for:
- molecular biology
- catalogue antibodies
- catalogue proteins
- elisa kits
The company’s research areas include cancer, epigenetics and nuclear signalling, cell and developmental biology, immunology and inflammation, stem cells, protein phosphorylation, signal transduction, endocrine system and metabolism, neuroscience and cardiovascular. Its popular pathways include epigenetic modifications, RNA binding, apoptosis, autophagy, AMPK signalling pathway, etc. The company has global distribution of its products in more than 140 countries worldwide, including Australia, Brazil, Germany, Israel, Egypt, Greece.
